Evelo Biosciences
(OTC) EVLO
Evelo Biosciences Financials at a Glance
Market Cap
$1,900
Revenue (TTM)
$0.00
Net Income (TTM)
$82.35M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-24.43 (Low)
Dividend
$0.00
Beta (Volatility)
-24.43 (Low)
Price
$0.00
Volume
466
Open
$0.00
Price
$0.00
Volume
466
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-24.43 (Low)
Price
$0.00
Volume
466
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
EVLO News
EVLO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Evelo Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
66
CEO
Simba Gill, PhD, MBA
Website
www.evelobio.comHeadquarters
Cambridge, MA 02139, US
EVLO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.90K
Shares Outstanding
18.98M
Volume
466
Short Interest
0.00%
Avg. Volume
883.839
Financials (TTM)
Gross Profit
$0.00
Operating Income
$108.47M
EBITDA
$106.34M
Operating Cash Flow
$101.23M
Capital Expenditure
$622.00K
Free Cash Flow
$101.86M
Cash & ST Invst.
$47.94M
Total Debt
$51.14M
Evelo Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$793.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.90K
N/A
Market Cap/Employee
$28.79
N/A
Employees
66
N/A
Net Income
$12.36M
+59.5%
EBITDA
$11.05M
+62.0%
Quarterly Fundamentals
Net Cash
$16.69M
-217.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$33.95M
+135.0%
Return on Assets
-1.78%
N/A
Return on Invested Capital
-2.08%
N/A
Free Cash Flow
$10.46M
+53.7%
Operating Cash Flow
$10.41M
+53.9%